Abstract
Background
Improving depression is critical to the success of HIV treatment. Concerns about the adverse effects of pharmacotherapy have led to non-pharmacological treatments for depression in people living with HIV (PLWH) becoming increasingly popular. However, the most effective and acceptable non-pharmacological treatments for depression in PLWH have not yet been determined. This protocol for a systematic review and network meta-analysis aims to compare and rank all available non-pharmacological treatments for depression in PLWH in the global network of countries as well as in the network of low-income and middle-income countries (LMICs) only.
Methods
We will include all randomized controlled trials of any non-pharmacological treatments for depression in PLWH. The primary outcomes will consider efficacy (the overall mean change scores in depression) and acceptability (all-cause discontinuation). Published and unpublished studies will be systematically searched through the relevant databases (PubMed, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), PsycINFO, CINAHL, ProQuest, and OpenGrey), international trial registers, and websites. There is no restriction by language and publication year. All study selection, quality evaluation, and data extraction will be independently conducted by at least two investigators. We will perform a random-effects network meta-analysis to synthesize all available evidence for each outcome and obtain a comprehensive ranking of all treatments for the global network of countries as well as for the network of LMICs only. We will employ validated global and local approaches to evaluate inconsistency. We will use OpenBUGS (version 3.2.3) software to fit our model within a Bayesian framework. We will evaluate the strength of evidence using the Confidence in Network Meta-Analysis (CINeMA) tool, a web application based on the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system.
Ethics and dissemination
This study will use secondary data and therefore does not require ethical approval. The results of this study will be disseminated through peer-reviewed publication.
Trial registration
PROSPERO registration number: CRD42021244230.
Funder
Natural Science Foundation of Hunan Province
National Natural Science Foundation of China
Publisher
Public Library of Science (PLoS)
Reference63 articles.
1. World Health Organization. HIV 2023 [https://www.who.int/news-room/fact-sheets/detail/hiv-aids.
2. Technology-delivered psychotherapeutic interventions in improving depressive symptoms among people with HIV/AIDS: a systematic review and meta-analysis of randomised controlled trials;LJ Cheng;AIDS Behav,2020
3. Beyond viral suppression of HIV—the new quality of life frontier;J Lazarus;BMC medicine,2016
4. Depression in HIV infected patients: a review;MG Nanni;Curr Psychiatry Rep,2015
5. Psychosocial group interventions to improve psychological well-being in adults living with HIV;I van der Heijden;Cochrane Database Syst Rev,2017